Recombinant Hepatitis E Vaccine (Escherichia Coli)

Hepatitis E vaccine (recombinant, E. coli expression) · Xiamen Innovax Biotech Co., Ltd.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Recombinant Hepatitis E Vaccine (Escherichia Coli), covering 2017-12-04 to 2020-05-07. Get the full timeline:

Most recent: Clinical Trial Update: A Phase Ⅳ Clinical Trial of the Recombinant Hepatitis E Vaccine (Escherichia Coli)(the Lot Consistency Trial) [Phase 4]

See pricing